Tonix Pharmaceuticals Holding Corp. Quarterly Costs and Expenses in USD from Q2 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly/annual Costs and Expenses history and growth rate from Q2 2015 to Q3 2024.
  • Tonix Pharmaceuticals Holding Corp. Costs and Expenses for the quarter ending September 30, 2024 was $18.4M, a 42.8% decline year-over-year.
  • Tonix Pharmaceuticals Holding Corp. Costs and Expenses for the twelve months ending September 30, 2024 was $153M, a 19.6% increase year-over-year.
  • Tonix Pharmaceuticals Holding Corp. annual Costs and Expenses for 2023 was $126M, a 12.5% increase from 2022.
  • Tonix Pharmaceuticals Holding Corp. annual Costs and Expenses for 2022 was $112M, a 21.4% increase from 2021.
  • Tonix Pharmaceuticals Holding Corp. annual Costs and Expenses for 2021 was $92.3M, a 82.8% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $153M $18.4M -$13.8M -42.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $167M $79.5M +$50.5M +174% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-16
Q1 2024 $116M $23.8M -$10.1M -29.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $126M $31.1M -$1.62M -4.95% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $128M $32.1M +$2.55M +8.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $125M $29M +$5.67M +24.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-16
Q1 2023 $120M $33.9M +$7.47M +28.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $112M $32.7M +$3.25M +11% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $109M $29.6M +$11.1M +59.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $97.8M $23.3M -$226K -0.96% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $98M $26.4M +$5.7M +27.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $92.3M $29.5M +$12.5M +73.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-13
Q3 2021 $79.9M $18.5M +$6.54M +54.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $73.3M $23.6M +$9.37M +66% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $64M $20.7M +$13.4M +184% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $50.5M $17M +$8.29M +94.9% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $42.2M $12M +$4.11M +52.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $38.1M $14.2M +$8.29M +140% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $29.8M $7.3M +$1M +15.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $28.8M $8.73M +$1.08M +14.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-15
Q3 2019 $27.7M $7.89M +$2.35M +42.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $25.4M $5.91M -$237K -3.86% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $25.6M $6.3M -$691K -9.89% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $26.3M $7.65M +$2.11M +38% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 $24.2M $5.54M -$294K -5.04% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 $24.5M $6.14M +$1.32M +27.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $23.2M $6.99M +$1.9M +37.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $21.3M $5.54M -$1.97M -26.2% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-03-18
Q3 2017 $23.3M $5.84M -$1.77M -23.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $25M $4.82M -$5.01M -51% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 $30M $5.09M -$8.92M -63.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 $39M $7.51M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-09
Q3 2016 $7.61M -$5.67M -42.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $9.84M -$1.95M -16.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $14M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-12
Q3 2015 $13.3M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $11.8M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.